Law firm probes fairness of Sila and Lisata shareholder deals amid potential insider benefits

Halper Sadeh LLC is investigating whether the sale transactions of Sila Realty Trust and Lisata Therapeutics provide fair value to their shareholders. The law firm alleges insiders may receive financial benefits not available to ordinary shareholders and that deal terms might restrict better competing offers. Sila is being sold to Blue Owl Real Estate Capital for $30.38 per share, while Lisata is being acquired by Kuva Labs for $4.00 per share plus contingent value rights. Shareholders are encouraged to explore their legal options, as the firm may seek increased compensation or additional disclosures on their behalf.